This brand name is authorized in Spain
The drug PRANZO contains a combination of these active pharmaceutical ingredients (APIs):
|
1
L-carnitine
UNII F64264D63N - CARNITINE CHLORIDE
|
|
Levocarnitine as a factor is necessary in the transport of long-chain fatty acids into the mitochondria-facilitating the oxidation of fatty acids rather than their incorporation into triglycerides. |
|
2
Lysine
UNII JNJ23Q2COM - LYSINE HYDROCHLORIDE
|
|
|
|
3
Cyproheptadine
UNII NJ82J0F8QC - CYPROHEPTADINE HYDROCHLORIDE
|
|
Cyproheptadine is a first generation antihistamine which also has anticholinergic and antiserotonergic activities that is used to treat allergic conditions including seasonal rhinitis, conjunctivitis, dermatitits and urticaria. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A15 | Appetite stimulants | A Alimentary tract and metabolism |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 47944 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
